22157.jpg
Insights on the Liposomal Doxorubicin Global Market to 2026 - by Product, Application and Region
06 déc. 2021 06h08 HE | Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
22157.jpg
China Nivolumab Market Market Report 2021: Sales Value Increased from CNY9.9 Million in 2018 to CNY 43.1 Million in 2020 - Forecast to 2025
02 juin 2021 04h33 HE | Research and Markets
Dublin, June 02, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Nivolumab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to this market...
22157.jpg
Global Liver Cancer Hepatoma Markets, Epidemiology and Patient Flow Report 2020-2035
17 mai 2021 06h43 HE | Research and Markets
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Global Liver Cancer Hepatoma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global Liver Cancer...
Logo.png
Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies
29 avr. 2021 20h30 HE | DelveInsight Business Research LLP
Los Angeles, USA, April 29, 2021 (GLOBE NEWSWIRE) -- Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies  A comprehensive analysis of...
22157.jpg
Global Hepatocellular Carcinoma Market Analysis 2019-2020 & 2029 - High Level of Unmet Needs Leaves Room for Further Research & Opportunity for Pipeline Agents with First-in-Class Approvals
15 avr. 2021 05h13 HE | Research and Markets
Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2029" report has been added to ResearchAndMarkets.com's offering. The pipeline drugs...
22157.jpg
Global Hepatocellular Carcinoma Treatment Market 2021-2025: Market Sizing, Market Forecast and Key Vendor Profiles
08 mars 2021 07h33 HE | Research and Markets
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Global Hepatocellular Carcinoma Treatment Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The hepatocellular carcinoma...
22157.jpg
Global Liver Cancer Therapeutics Markets Report 2020: Historical Data 2015-2018, Base Year of 2019, Estimates for 2020 & Forecasts 2021-2025
19 janv. 2021 07h33 HE | Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "Global Liver Cancer Therapeutics Market, by Cancer Type, by Therapy, by Equipment, by Age, by Factors, by Route of Administration, by Distribution...
22157.jpg
Hepatocellular Carcinoma Epidemiology Forecast Report 2020: Diagnosed Incident Cases and Five-year Diagnosed Prevalent Cases for 2019-2029
12 janv. 2021 09h43 HE | Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The Hepatocellular Carcinoma...
AMR Logo.png
North America Liver Disease Treatment Market to Hit $8.31 Billion by 2027: AMR
26 oct. 2020 09h56 HE | Allied Market Research
Portland, Oct. 26, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the North America Liver Disease Treatment Market accounted for $6.97 billion in 2019, and is...
22157.jpg
Liver Cancer Hepatoma Clinical Trials Pipeline 2020 and Products Forecast to 2025
07 sept. 2020 07h18 HE | Research and Markets
Dublin, Sept. 07, 2020 (GLOBE NEWSWIRE) -- The "Global Liver Cancer Hepatoma Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering. The report...